Conclusion: The Siemens Healthineers’ StrokeSegApp provides accurate automated segmentation of ischemic stroke lesions, comparable to human experts as well as ... data of diffusion (TraceW and ADC ...

Co., Inc. (NYSE:MRK), a global healthcare leader, finds itself at a crossroads as it navigates challenges in its China Gardasil business while capitalizing on opportunities in pulmonary arterial ...

Herrmann will continue in her role as chief of staff to EVP and chief communications and public affairs officer Cristal Downing.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical ...

Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the pharmaceutical giant.

The global Veterinary Vaccines market, valued at US$8.93 billion in 2023, is forecasted to grow at a robust CAGR of 6.1%, reaching US$9.39 billion in 2024 and an impressive US$13.33 billion by 2029.

Merck MRK stock has declined 8.8% in the past three months. Merck faces its share of headwinds like declining sales of the human papillomavirus (HPV) vaccine, Gardasil, and diabetes drug ...

Merck & Co. Inc. (NYSE ... operates worldwide through the following two segments. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute ...

Today's Research Daily features new research reports on 16 major stocks, including Chevron Corporation (c), Merck & Co., Inc. (MRK ... on key customers adding revenue volatility. HPP segment revenue ...